Clinical trial
A Clinical Study Assessing the Potential of Piboserod for the Treatment of Heart…
NCT00421746 · Bio-Medisinsk Innovasjon, Industry · Completed
Key facts
| NCT number | NCT00421746 |
|---|---|
| Title | A Clinical Study Assessing the Potential of Piboserod for the Treatment of Heart Failure |
| Official title | A Proof of Biological Efficacy Study Assessing the Potential of Piboserod, a Specific 5-HT4 Antagonist, for the Treatment of Symptomatic Congestive Heart Failure on Top of Usual Evidence Based Pharmacological Treatment |
| Lead sponsor | Bio-Medisinsk Innovasjon, Industry |
| Collaborators | Smerud Medical Research International AS |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure |
| Intervention type | Drug |
| Interventions | Piboserod |
| Enrollment | 137 |
| Start date | Jan 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Jan 12, 2007 |
| Last update posted | Aug 3, 2007 |
| Countries | Denmark, Norway, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: